Vijaya Diagnostic Centre Limited — Investor Meet, 15-05-2025: Analysts/Institutional Investor Meet/Con. Call Updates

Vijaya Diagnostic Centre reported Q4 consolidated revenue of INR173 Cr, up 12% YoY, driven by organic volume growth. EBITDA stood at INR69 Cr (39.8% margin) and PAT at INR35 Cr (20% margin). FY25 revenue grew 24% to INR681 Cr, EBITDA 24% to INR273 Cr, and PAT at INR143 Cr. Rapid hub expansion accelerated with six new hubs launched; margin dip of 1-2% expected in FY26 due to new hubs, recovering by FY27. Focus remains on brand, technology upgrades, and direct B2C engagement. Industry growth at 11-12%, Vijaya outpaces peers with integrated diagnostics and geographic diversification. Capex planned at INR145-150 Cr to add 10 hubs; pricing hikes of 1-2% and volume-led growth expected. Strong cash (~INR200 Cr) supports expansion; outlook is confident on steady growth and margin recovery.